Martin-Rodriguez, Jose LuisGonzalez-Cantero, JorgeGonzalez-Cantero, AlvaroArrebola, Juan PedroGonzalez-Calvin, Jorge Luis2023-01-252023-01-252017http://hdl.handle.net/10668/11133Recognition of the close relationship of nonalcoholic fatty liver disease (NAFLD) with diabetes mellitus 2, obesity, metabolic syndrome, and cardiovascular disease has stimulated growing interest in NAFLD as a public health problem. Serum alanine aminotransferase (ALT) has been proposed as a marker of NAFLD, but levels are within the range currently considered "normal" in a large proportion of NAFLD subjects.The aim of the study was to determine the diagnostic accuracy of serum ALT for identifying individuals with NAFLD, using 3-Tesla (T) magnetic resonance spectroscopy (H-MRS).A cross-sectional study was conducted in 129 healthy subjects. Liver triglyceride content was quantified by H-MRS. NAFLD was defined as liver triglyceride content greater than 5.56%.Liver triglyceride content was >5.56% in 79 participants (NAFLD) and lower in the remaining 50 (normal). Serum ALT levels correlated positively with liver triglyceride content (r = 0.58, P 5.56% in 79 participants (NAFLD) and lower in the remaining 50 (normal). Serum ALT levels correlated positively with liver triglyceride content (r = 0.58, P enAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/AdultAgedAlanine TransaminaseAnthropometryArea Under CurveBiomarkersFemaleHumansInsulin ResistanceLiverMaleMiddle AgedNon-alcoholic Fatty Liver DiseaseProton Magnetic Resonance SpectroscopyROC CurveRegression AnalysisTriglyceridesWhite PeopleYoung AdultDiagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.research article28445310open access10.1097/MD.00000000000067701536-5964PMC5413275https://doi.org/10.1097/md.0000000000006770https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413275/pdf